PayerIQ
Sun, May 24, 2026
Back to universe
Tier 3GANational
Centene Corporation
Monitor & nurture — quarterly touchpoints + data sharing
Composite
56.8
Rank
#168
Members
27.5M
Scoring profile
Six-criterion radar
Breakdown
Weighted score contribution
Claims
25%
51
+12.8
Lives
20%
65
+13.0
Geography
20%
67
+13.4
Restrictions
15%
45
+6.8
Relationship
10%
53
+5.3
Financials
10%
56
+5.6
Composite Score56.8
Composite = Claims×0.25 + Lives×0.20 + Geography×0.20 + Restrictions×0.15 + Relationship×0.10 + Financials×0.10
= 12.8 + 13.0 + 13.4 + 6.8 + 5.3 + 5.6 = 56.8
Intelligence
Qualitative intelligence
Members
27.5M
Drug spend
$8.3B
Formulary
4-tier
PA / RA level
Very High
Biosimilar policy
Step therapy required
Avg reimbursement
40 days
Strategic notes
Outperforms nationals in local market; key state champion opportunity
Playbook · Tier 3
Engagement timeline
Week 2
Account manager check-in
Bi-annually
Formulary monitoring report